Market Overview:
The global sickle cell disease treatment market size reached US$
2.6 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$
6.4 Billion by 2027, exhibiting a growth rate (CAGR) of
16.0% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Sickle cell disease (SCD) is a genetic red blood cell (RBC) disorder that affects hemoglobin, a protein that carries oxygen throughout the body. It leads to many complications, such as acute chest syndrome, anemia, and vaso-occlusive crisis (VOC). At present, blood and bone marrow transplant is commonly suggested by doctors for treating SCD. It involves replacing affected bone marrow with a healthy substitute received from a donor. Other effective treatments, such as medications and blood transfusions, are also being utilized as they can reduce specific symptoms and prolong the life of patients.
www.imarcgroup.com
Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.
A considerable increase in the number of individuals suffering from SCD represents one of the significant factors influencing the demand for new medications that can treat the condition effectively. As a result, the health regulatory authorities of numerous countries are focusing on fast-track approval of new treatment methods. For instance, the United States Food and Drug Administration (USFDA) approved a new medicine in 2019 to reduce the pain experienced by adults and children with SCD. Additionally, government authorities are supporting research and development (R&D) activities to encourage researchers and pharmaceutical companies to develop novel treatments. For instance, researchers at the National Heart, Lung, and Blood Institute (NHLBI) in the US are working on genetic therapies that can restore a missing gene or add a new DNA strain to improve the functioning of cells. These innovations, along with the rising disposable incomes and the growing awareness among individuals about the available healthcare services, are anticipated to contribute to market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global sickle cell disease treatment market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on treatment type and end user.
Breakup by Treatment Type:
www.imarcgroup.com
Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.
- Blood Transfusion
- Pharmacotherapy
- Bone Marrow Transplant
Breakup by End User:
- Hospitals
- Diagnostic Centers
- Others
Breakup by Region:
To get more information on the regional analysis of this market, Request Sample
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AstraZeneca Plc, Baxter International Inc., bluebird bio Inc., Bristol-Myers Squibb Company, CRISPR Therapeutics, Emmaus Medical Inc., Global Blood Therapeutics Inc., GlycoMimetics Inc., Novartis AG, Pfizer Inc. and Sangamo Therapeutics.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Historical Period |
2016-2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Billion |
| Segment Coverage |
Treatment Type, End User, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
AstraZeneca Plc, Baxter International Inc., bluebird bio Inc., Bristol-Myers Squibb Company, CRISPR Therapeutics, Emmaus Medical Inc., Global Blood Therapeutics Inc., GlycoMimetics Inc., Novartis AG, Pfizer Inc. and Sangamo Therapeutics |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global sickle cell disease treatment market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global sickle cell disease treatment market?
- What are the key regional markets?
- What is the breakup of the market based on the treatment type?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global sickle cell disease treatment market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Sickle Cell Disease Treatment Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Treatment Type
6.1 Blood Transfusion
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Pharmacotherapy
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Bone Marrow Transplant
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by End User
7.1 Hospitals
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Diagnostic Centers
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia-Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 AstraZeneca Plc
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 Baxter International Inc.
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.2.4 SWOT Analysis
13.3.3 bluebird bio Inc.
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Financials
13.3.3.4 SWOT Analysis
13.3.4 Bristol-Myers Squibb Company
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Financials
13.3.4.4 SWOT Analysis
13.3.5 CRISPR Therapeutics
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Financials
13.3.6 Emmaus Medical Inc.
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 Financials
13.3.7 Global Blood Therapeutics Inc.
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 Financials
13.3.8 GlycoMimetics Inc.
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
13.3.9 Novartis AG
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.9.4 SWOT Analysis
13.3.10 Pfizer Inc.
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.10.3 Financials
13.3.10.4 SWOT Analysis
13.3.11 Sangamo Therapeutics
13.3.11.1 Company Overview
13.3.11.2 Product Portfolio
13.3.11.3 Financials
13.3.11.4 SWOT Analysis
List of Figures
Figure 1: Global: Sickle Cell Disease Treatment Market: Major Drivers and Challenges
Figure 2: Global: Sickle Cell Disease Treatment Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Sickle Cell Disease Treatment Market: Breakup by Treatment Type (in %), 2021
Figure 5: Global: Sickle Cell Disease Treatment Market: Breakup by End User (in %), 2021
Figure 6: Global: Sickle Cell Disease Treatment Market: Breakup by Region (in %), 2021
Figure 7: Global: Sickle Cell Disease Treatment (Blood Transfusion) Market: Sales Value (in Million US$), 2016 & 2021
Figure 8: Global: Sickle Cell Disease Treatment (Blood Transfusion) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 9: Global: Sickle Cell Disease Treatment (Pharmacotherapy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Sickle Cell Disease Treatment (Pharmacotherapy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Sickle Cell Disease Treatment (Bone Marrow Transplant) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Sickle Cell Disease Treatment (Bone Marrow Transplant) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Sickle Cell Disease Treatment (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Sickle Cell Disease Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Sickle Cell Disease Treatment (Diagnostic Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Sickle Cell Disease Treatment (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Sickle Cell Disease Treatment (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Sickle Cell Disease Treatment (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: North America: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: North America: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: United States: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: United States: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Canada: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Canada: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Asia-Pacific: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Asia-Pacific: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: China: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: China: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Japan: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Japan: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: India: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: India: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: South Korea: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: South Korea: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Australia: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Australia: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Indonesia: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Indonesia: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Others: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Others: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Europe: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Europe: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Germany: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Germany: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: France: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: France: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: United Kingdom: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: United Kingdom: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Italy: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Italy: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Spain: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Spain: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Russia: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Russia: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Others: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Others: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Latin America: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Latin America: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Brazil: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Brazil: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Mexico: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Mexico: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Others: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Others: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Middle East and Africa: Sickle Cell Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Middle East and Africa: Sickle Cell Disease Treatment Market: Breakup by Country (in %), 2021
Figure 67: Middle East and Africa: Sickle Cell Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Global: Sickle Cell Disease Treatment Industry: SWOT Analysis
Figure 69: Global: Sickle Cell Disease Treatment Industry: Value Chain Analysis
Figure 70: Global: Sickle Cell Disease Treatment Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Sickle Cell Disease Treatment Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Sickle Cell Disease Treatment Market Forecast: Breakup by Treatment Type (in Million US$), 2022-2027
Table 3: Global: Sickle Cell Disease Treatment Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 4: Global: Sickle Cell Disease Treatment Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 5: Global: Sickle Cell Disease Treatment Market: Competitive Structure
Table 6: Global: Sickle Cell Disease Treatment Market: Key Players